Aliases & Classifications for Bone Disease

MalaCards integrated aliases for Bone Disease:

Name: Bone Disease 12 15 17
Bone Diseases 54 42 43 15 71
Disorder of Skeletal System 71
Skeletal Disorder 54
Skeletal Disease 12

Classifications:



External Ids:

Disease Ontology 12 DOID:0080001
MeSH 43 D001847
SNOMED-CT 67 76069003
ICD10 32 M89 M89.8 M89.9
UMLS 71 C0005940 C0263661

Summaries for Bone Disease

MedlinePlus : 42 Your bones help you move, give you shape and support your body. They are living tissues that rebuild constantly throughout your life. During childhood and your teens, your body adds new bone faster than it removes old bone. After about age 20, you can lose bone faster than you make bone. To have strong bones when you are young, and to prevent bone loss when you are older, you need to get enough calcium, vitamin D, and exercise. You should also avoid smoking and drinking too much alcohol. Bone diseases can make bones easy to break. Different kinds of bone problems include Low bone density and osteoporosis, which make your bones weak and more likely to break Osteogenesis imperfecta makes your bones brittle Paget's disease of bone makes them weak Bones can also develop cancer and infections Other bone diseases, which are caused by poor nutrition, genetics, or problems with the rate of bone growth or rebuilding NIH: National Institute of Arthritis and Musculoskeletal and Skin Diseases

MalaCards based summary : Bone Disease, also known as bone diseases, is related to ischemic bone disease and brittle bone disorder, and has symptoms including back pain, bone pain and sciatica. An important gene associated with Bone Disease is DANCR (Differentiation Antagonizing Non-Protein Coding RNA), and among its related pathways/superpathways are RANK Signaling in Osteoclasts and Osteoclast differentiation. The drugs Acetaminophen and Tocopherol have been mentioned in the context of this disorder. Affiliated tissues include bone, kidney and breast, and related phenotypes are cellular and growth/size/body region

Disease Ontology : 12 A connective tissue disease that affects the structure or development of bone or causes an impairment of normal bone function.

Wikipedia : 74 Bone disease refers to the medical conditions which affect the... more...

Related Diseases for Bone Disease

Diseases in the Bone Disease family:

Trpv4-Related Bone Disorder

Diseases related to Bone Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 805, show less)
# Related Disease Score Top Affiliating Genes
1 ischemic bone disease 34.7 TNFSF11 TNFRSF11B SOST RUNX2 PTH DKK1
2 brittle bone disorder 34.1 TNFSF11 TNFRSF11B SOST RUNX2 PTH FGFR3
3 gorham's disease 34.1 TNFSF11 PTH CALCA
4 paget disease of bone 5, juvenile-onset 34.0 TNFSF11 TNFRSF11B TNFRSF11A CALCA
5 osteopetrosis 34.0 TNFSF11 TNFRSF11B TNFRSF11A RUNX2 CTSK CALCA
6 osteitis fibrosa 33.4 SOST PTH FGF23 CALCA BGLAP B2M
7 paget's disease of bone 33.4 TNFSF11 TNFRSF11B TNFRSF11A SOST PTH DKK1
8 osteonecrosis 33.3 TNFSF11 TNFRSF11B RUNX2 PTH DKK1 BGLAP
9 renal osteodystrophy 33.0 VDR TNFSF11 TNFRSF11B SOST PTH FGF23
10 primary hyperparathyroidism 32.9 VDR TNFSF11 TNFRSF11B SOST PTH FGF23
11 arthropathy 32.9 TNFSF11 TNFRSF11B TNFRSF11A B2M ALPL
12 hypophosphatasia 32.9 RUNX2 PTH FGF23 BGLAP ALPP ALPL
13 chronic kidney disease 32.8 VDR TNFSF11 TNFRSF11B SOST RUNX2 PTH
14 cherubism 32.7 TNFSF11 FGFR3 CALCA
15 hypophosphatasia, adult 32.4 PTH ALPL
16 osteopetrosis, autosomal dominant 2 32.4 TNFSF11 BGLAP ACP5
17 osteopetrosis, autosomal recessive 2 32.3 TNFSF11 CTSK ACP5
18 cleidocranial dysplasia 32.3 RUNX2 BGLAP ALPP ALPL
19 metachondromatosis 32.3 EXT2 EXT1 CTSK
20 enchondromatosis, multiple, ollier type 32.3 RUNX2 PTH FGFR3 EXT2 EXT1 ACP5
21 hypophosphatasia, childhood 32.3 PTH ALPP ALPL
22 bone development disease 32.2 SOST RUNX2 PTH FGFR3 CTSK BGLAP
23 bone resorption disease 32.2 VDR TNFSF11 TNFRSF11B TNFRSF11A SOST RUNX2
24 hyperparathyroidism 32.1 VDR TNFSF11 TNFRSF11B SOST PTH FGF23
25 osteomalacia 32.1 VDR TNFSF11 SOST PTH FGF23 CALCA
26 myeloma, multiple 32.0 TNFSF11 TNFRSF11B SOST RUNX2 PTH FGFR3
27 mammary paget's disease 32.0 TNFSF11 TNFRSF11B TNFRSF11A PTH CTSK CALCA
28 rickets 31.9 VDR PTH FGF23 CALCA BGLAP ALPP
29 bone remodeling disease 31.9 VDR TNFSF11 TNFRSF11B TNFRSF11A SOST RUNX2
30 kidney disease 31.9 VDR TNFRSF11B PTH FGF23 BGLAP B2M
31 secondary hyperparathyroidism 31.8 VDR TNFRSF11B PTH FGF23 CALCA BGLAP
32 osteoporosis 31.8 VDR TNFSF11 TNFRSF11B TNFRSF11A SOST RUNX2
33 osteomyelitis 31.6 TNFSF11 CTSK CALCA ALPL ACP5
34 hypoparathyroidism 31.5 VDR PTH FGF23 CALCA BGLAP ALPP
35 hyperphosphatemia 31.5 VDR TNFRSF11B RUNX2 PTH FGF23 BGLAP
36 endosteal hyperostosis, autosomal dominant 31.4 TNFSF11 TNFRSF11B SOST CTSK ACP5
37 hypophosphatemia 31.4 VDR PTH FGF23 BGLAP B2M ALPL
38 uremia 31.4 VDR TNFRSF11B PTH B2M
39 hyperthyroidism 31.3 PTH CALCA BGLAP ALPP ACP5
40 fibrous dysplasia 31.3 TNFSF11 TNFRSF11B TNFRSF11A RUNX2 FGF23 CALCA
41 bone cancer 31.2 VDR TNFSF11 TNFRSF11B TNFRSF11A PTH CALCA
42 hyperostosis 31.2 TNFRSF11B SOST FGF23 ALPL
43 osteogenic sarcoma 31.2 VDR TNFSF11 TNFRSF11B RUNX2 PTH DANCR
44 parathyroid adenoma 31.2 VDR PTH CALCA BGLAP ALPP
45 nephrolithiasis 31.1 VDR TNFRSF11B PTH FGF23 BGLAP B2M
46 glucocorticoid-induced osteoporosis 31.1 VDR TNFSF11 TNFRSF11B SOST RUNX2 PTH
47 arthritis 31.1 TNFSF11 TNFRSF11A PTH CTSK ACP5
48 sclerosteosis 31.1 VDR TNFSF11 TNFRSF11B SOST RUNX2 PTH
49 idiopathic hypercalciuria 31.1 VDR TNFSF11 BGLAP
50 monoclonal gammopathy of uncertain significance 31.1 FGFR3 DKK1 B2M
51 osteoarthritis 30.9 TNFSF11 TNFRSF11B RUNX2 BGLAP
52 multicentric carpotarsal osteolysis syndrome 30.9 TNFSF11 TNFRSF11B TNFRSF11A CTSK BGLAP ACP5
53 diabetes mellitus 30.9 VDR TNFSF11 TNFRSF11B PTH FGF23 CALCA
54 synovitis 30.9 TNFSF11 TNFRSF11B ACP5
55 periodontitis 30.9 VDR TNFSF11 TNFRSF11B RUNX2 CTSK BGLAP
56 osteoporosis-pseudoglioma syndrome 30.9 TNFRSF11B SOST DKK1
57 chronic recurrent multifocal osteomyelitis 30.8 TNFSF11 BGLAP ALPL
58 rheumatoid arthritis 30.8 TNFSF11 TNFRSF11B TNFRSF11A PTH CTSK BGLAP
59 familial expansile osteolysis 30.8 TNFSF11 TNFRSF11B TNFRSF11A
60 spondylitis 30.8 TNFSF11 SOST DKK1
61 pseudohypoparathyroidism 30.8 PTH FGFR3 CALCA BGLAP
62 scoliosis 30.8 VDR TNFSF11 TNFRSF11B TNFRSF11A RUNX2 FGFR3
63 ankylosis 30.8 TNFSF11 TNFRSF11B RUNX2 BGLAP
64 osteoporosis, juvenile 30.8 TNFSF11 TNFRSF11B SOST RUNX2 PTH DKK1
65 spondyloarthropathy 1 30.7 TNFSF11 TNFRSF11B PTH BGLAP B2M
66 pycnodysostosis 30.7 TNFSF11 SOST CTSK ACP5
67 hypercalcemia, infantile, 1 30.7 VDR PTH CALCA
68 fanconi syndrome 30.7 PTH FGF23 B2M
69 aneurysmal bone cysts 30.6 TNFSF11 TNFRSF11A CALCA
70 benign giant cell tumor 30.6 TNFSF11 TNFRSF11B TNFRSF11A FGF23 CTSK CALCA
71 van buchem disease 30.6 VDR TNFSF11 TNFRSF11B SOST RUNX2 PTH
72 calciphylaxis 30.6 VDR PTH FGF23
73 mccune-albright syndrome 30.5 SOST FGF23 BGLAP ALPP
74 periostitis 30.5 TNFRSF11B TNFRSF11A ALPP
75 pfeiffer syndrome 30.5 RUNX2 FGFR3 BGLAP ALPL
76 craniometaphyseal dysplasia, autosomal dominant 30.4 TNFSF11 RUNX2 BGLAP ALPL
77 bone giant cell tumor 30.4 TNFSF11 TNFRSF11B TNFRSF11A PTH CTSK CALCA
78 dysostosis 30.4 TNFSF11 RUNX2 FGFR3 EXT2
79 odontochondrodysplasia 30.4 TNFSF11 TNFRSF11B SOST RUNX2 PTH FGFR3
80 chondrosarcoma 30.4 RUNX2 FGFR3 EXT2 EXT1
81 hypervitaminosis d 30.4 VDR PTH FGF23 CALCA
82 camurati-engelmann disease 30.3 SOST RUNX2 BGLAP ACP5
83 connective tissue disease 30.3 TNFSF11 TNFRSF11B RUNX2 PTH BGLAP
84 periarthritis 30.3 B2M ALPL
85 hereditary multiple osteochondromas 30.3 EXT2 EXT1
86 microphthalmia 30.2 TNFSF11 FGFR3 DKK1 CTSK ACP5
87 oncogenic osteomalacia 30.2 PTH FGF23
88 exostosis 30.1 EXT2 EXT1 CALCA BGLAP
89 ossification of the posterior longitudinal ligament of spine 29.5 RUNX2 BGLAP
90 polycystic bone disease 12.3
91 hypophosphatemic bone disease 12.2
92 rare genetic bone disease 12.2
93 pierre robin syndrome associated with bone disease 12.1
94 rare bone disease related to a common gene or pathway defect 12.0
95 cystic angiomatosis of bone, diffuse 11.7
96 col1a1/2 osteogenesis imperfecta 11.4
97 thanatophoric dysplasia, type i 11.3
98 diaphanospondylodysostosis 11.3
99 bone inflammation disease 11.2
100 inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 1 11.2
101 gaucher's disease 11.1
102 osteonecrosis of the jaw 11.1
103 gaucher disease, type i 11.1
104 exostoses, multiple, type ii 11.1
105 exostoses, multiple, type i 11.1
106 diastrophic dysplasia 11.1
107 atelosteogenesis, type ii 11.1
108 achondrogenesis, type ib 11.1
109 bent bone dysplasia syndrome 11.1
110 coxa vara 11.1
111 hajdu-cheney syndrome 11.0
112 hypophosphatasia, infantile 11.0
113 langerhans cell histiocytosis 11.0
114 dysbaric osteonecrosis 11.0
115 spinal stenosis 11.0
116 osteochondrosis 11.0
117 acrocapitofemoral dysplasia 11.0
118 inclusion body myopathy with paget disease of bone and frontotemporal dementia 11.0
119 mesomelic dysplasia, kantaputra type 10.9
120 lateral meningocele syndrome 10.9
121 metatropic dysplasia 10.9
122 polyarticular onset juvenile idiopathic arthritis 10.9 TNFSF11 TNFRSF11B TNFRSF11A
123 hyperparathyroidism, transient neonatal 10.9
124 hemophilic arthropathy 10.9 TNFSF11 TNFRSF11B TNFRSF11A
125 kummell's disease 10.9 TNFSF11 TNFRSF11B SOST DKK1
126 disseminated chorioretinitis 10.8 TNFSF11 TNFRSF11B TNFRSF11A
127 periapical periodontitis 10.8 TNFSF11 TNFRSF11B CTSK ACP5
128 malignant ovarian brenner tumor 10.8 TNFSF11 PTH CALCA
129 giant cell reparative granuloma 10.8 TNFSF11 TNFRSF11A PTH CALCA
130 tooth resorption 10.8 TNFSF11 TNFRSF11B TNFRSF11A RUNX2 CTSK CALCA
131 root resorption 10.8 VDR TNFSF11 TNFRSF11B TNFRSF11A RUNX2 CTSK
132 pigmented villonodular synovitis 10.8 TNFSF11 TNFRSF11B ACP5
133 sclerosteosis 1 10.8 SOST DKK1 BGLAP
134 nontoxic goiter 10.8 PTH CALCA BGLAP
135 chondrodysplasia, blomstrand type 10.8 TNFSF11 PTH BGLAP
136 villonodular synovitis 10.8 TNFSF11 ACP5
137 hypocalcemia, autosomal dominant 1 10.8 VDR PTH FGF23 CALCA BGLAP
138 phosphorus metabolism disease 10.8 VDR RUNX2 PTH FGF23 BGLAP
139 bone benign neoplasm 10.8 PTH FGF23 BGLAP
140 parathyroid gland disease 10.8 VDR TNFSF11 TNFRSF11B SOST PTH FGF23
141 periodontitis, chronic 10.8 TNFSF11 TNFRSF11B
142 aggressive periodontitis 10.8 VDR TNFSF11 TNFRSF11B
143 teeth hard tissue disease 10.8 TNFSF11 TNFRSF11B ACP5
144 metaphyseal chondrodysplasia, jansen type 10.8 PTH FGFR3 FGF23
145 pediatric ovarian germ cell tumor 10.8 PTH ALPP
146 saethre-chotzen syndrome 10.8 RUNX2 FGFR3 BGLAP ALPP
147 basilar impression, primary 10.8
148 kyphomelic dysplasia 10.8
149 geleophysic dysplasia 3 10.8
150 mineral metabolism disease 10.8 VDR TNFSF11 TNFRSF11B RUNX2 PTH FGF23
151 pediatric ovarian dysgerminoma 10.8 PTH ALPP
152 osseous heteroplasia, progressive 10.8 RUNX2 PTH BGLAP
153 hypersensitivity reaction type iv disease 10.8 PTH ALPP ALPL
154 substernal goiter 10.8 PTH CALCA
155 anemia, congenital dyserythropoietic, type iii 10.7
156 brachyolmia type 3 10.7
157 klippel-feil syndrome 1, autosomal dominant 10.7
158 cleidorhizomelic syndrome 10.7
159 epiphyseal dysplasia, multiple, 1 10.7
160 chromosome 8q22.1 duplication syndrome 10.7
161 kniest dysplasia 10.7
162 spondyloepiphyseal dysplasia congenita 10.7
163 achondrogenesis, type ii 10.7
164 chondrodysplasia, grebe type 10.7
165 klippel-feil syndrome 2, autosomal recessive 10.7
166 mucopolysaccharidosis, type iva 10.7
167 osteopetrosis, autosomal recessive 5 10.7
168 osteopetrosis, autosomal recessive 3 10.7
169 spondylocostal dysostosis 1, autosomal recessive 10.7
170 winchester syndrome 10.7
171 spondyloepiphyseal dysplasia tarda, x-linked 10.7
172 epiphyseal dysplasia, multiple, 2 10.7
173 spondylospinal thoracic dysostosis 10.7
174 acromesomelic dysplasia, maroteaux type 10.7
175 intervertebral disc disease 10.7
176 osteopetrosis, autosomal dominant 1 10.7
177 acromesomelic dysplasia, demirhan type 10.7
178 osteopetrosis, autosomal recessive 4 10.7
179 osteopetrosis, autosomal recessive 6 10.7
180 osteopetrosis, autosomal recessive 7 10.7
181 klippel-feil syndrome 3, autosomal dominant 10.7
182 klippel-feil syndrome 4, autosomal recessive, with nemaline myopathy and facial dysmorphism 10.7
183 spondyloepimetaphyseal dysplasia, faden-alkuraya type 10.7
184 spondyloepimetaphyseal dysplasia, di rocco type 10.7
185 spondyloepimetaphyseal dysplasia, krakow type 10.7
186 acromesomelic dysplasia 10.7
187 multicentric reticulohistiocytosis 10.7 TNFSF11 TNFRSF11B
188 hemiplegia 10.7 CALCA BGLAP ACP5
189 microcephaly and chorioretinopathy 1 10.7 FGF23 ALPL
190 chiari malformation 10.7 FGFR3 DKK1
191 atelosteogenesis, type i 10.7
192 calvarial doughnut lesions with bone fragility 10.7
193 ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension 10.7
194 paget disease of bone 3 10.7
195 parastremmatic dwarfism 10.7
196 spondyloepimetaphyseal dysplasia, strudwick type 10.7
197 spondylometaphyseal dysplasia, kozlowski type 10.7
198 multiple synostoses syndrome 1 10.7
199 hypophosphatemic rickets, autosomal dominant 10.7
200 opsismodysplasia 10.7
201 spondyloepimetaphyseal dysplasia, sponastrime type 10.7
202 spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures 10.7
203 spondylometaepiphyseal dysplasia, short limb-hand type 10.7
204 spondyloepimetaphyseal dysplasia, x-linked 10.7
205 premature ovarian failure 1 10.7
206 paget disease of bone 2, early-onset 10.7
207 spondyloepimetaphyseal dysplasia, missouri type 10.7
208 renal tubular acidosis, distal, autosomal recessive 10.7
209 spondyloepimetaphyseal dysplasia with joint laxity, type 2 10.7
210 spondyloepimetaphyseal dysplasia, matrilin-3 related 10.7
211 multiple synostoses syndrome 2 10.7
212 spondyloepimetaphyseal dysplasia, aggrecan type 10.7
213 multiple synostoses syndrome 3 10.7
214 catel-manzke syndrome 10.7
215 multiple synostoses syndrome 4 10.7
216 spondyloepimetaphyseal dysplasia with joint laxity, type 3 10.7
217 spondyloepimetaphyseal dysplasia, isidor-toutain type 10.7
218 cole-carpenter syndrome 10.7
219 spinal disease 10.7
220 bone structure disease 10.7
221 gastroparesis 10.7
222 melorheostosis 10.7
223 osteochondritis dissecans 10.7
224 crystal arthropathies 10.7
225 syndromic craniosynostosis 10.7 RUNX2 FGFR3
226 granulomatous hepatitis 10.7 ALPP ALPL
227 uremic neuropathy 10.7 PTH B2M
228 nephrolithiasis/osteoporosis, hypophosphatemic, 1 10.7 PTH FGF23
229 synovial chondromatosis 10.7 RUNX2 FGFR3
230 breast leiomyosarcoma 10.7 TNFSF11 B2M
231 trichorhinophalangeal syndrome, type ii 10.6 TNFRSF11B EXT2 EXT1
232 dysplasia epiphysealis hemimelica 10.6 EXT2 EXT1
233 dental abscess 10.6 PTH FGF23
234 hypertelorism, microtia, facial clefting syndrome 10.6 TNFSF11 FGFR3
235 aortic valve disease 2 10.6 TNFSF11 TNFRSF11B RUNX2
236 osteochondroma 10.6 FGFR3 EXT2 EXT1
237 parietal foramina 10.6 RUNX2 FGFR3 EXT2
238 tracheal calcification 10.6 PTH FGF23
239 bone mineral density quantitative trait locus 8 10.6
240 bone mineral density quantitative trait locus 15 10.6
241 hypophosphatemic rickets with hypercalciuria, hereditary 10.6 PTH FGF23
242 avascular necrosis 10.6
243 juxtacortical chondroma 10.6 EXT2 EXT1
244 endemic goiter 10.5 PTH CALCA
245 chronic apical periodontitis 10.5 TNFSF11 TNFRSF11B
246 ankylosing spondylitis 3 10.5 EXT2 EXT1
247 bone sarcoma 10.5 RUNX2 EXT2 EXT1
248 craniodiaphyseal dysplasia 10.5 SOST DKK1
249 dental pulp necrosis 10.4 TNFSF11 BGLAP
250 end stage renal disease 10.2
251 bone mineral density quantitative trait locus 3 10.2
252 liver cirrhosis 10.2
253 hypogonadism 10.2
254 cystic fibrosis 10.1
255 primary biliary cirrhosis 10.1
256 liver disease 10.1
257 severe combined immunodeficiency 10.1
258 breast cancer 10.1
259 inflammatory bowel disease 10.1
260 thalassemia 10.1
261 fibrosis of extraocular muscles, congenital, 1 10.1
262 prostate cancer 10.0
263 metabolic acidosis 10.0
264 cholestasis 10.0
265 renal tubular acidosis 10.0
266 overnutrition 10.0
267 adenoma 10.0
268 hemosiderosis 10.0
269 rare hereditary hemochromatosis 10.0
270 short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans 9.9
271 acromegaly 9.9
272 crohn's disease 9.9
273 anemia, x-linked, with or without neutropenia and/or platelet abnormalities 9.9
274 deficiency anemia 9.9
275 nephrocalcinosis 9.9
276 myopathy 9.9
277 neurofibromatosis, type ii 9.9
278 celiac disease 1 9.9
279 graves disease 1 9.9
280 hypophosphatemic rickets, x-linked recessive 9.9
281 complement factor b deficiency 9.9
282 autosomal recessive disease 9.9
283 amyloidosis 9.9
284 leukemia 9.9
285 hypothyroidism 9.9
286 distal renal tubular acidosis 9.9
287 autoimmune disease 9.8
288 triiodothyronine receptor auxiliary protein 9.8
289 anorexia nervosa 9.8
290 leptin deficiency or dysfunction 9.8
291 urolithiasis 9.8
292 cystinosis 9.8
293 ulcerative colitis 9.8
294 47,xyy 9.8
295 sickle cell disease 9.8
296 cytokine deficiency 9.8
297 splenomegaly 9.8
298 thyroid carcinoma 9.8
299 pseudoachondroplasia 9.8
300 achondroplasia 9.8
301 renal cell carcinoma, nonpapillary 9.8
302 hypervitaminosis a 9.8
303 immune deficiency disease 9.8
304 insulin-like growth factor i 9.8
305 hypophosphatemic rickets, x-linked dominant 9.8
306 fanconi renotubular syndrome 2 9.8
307 beta-thalassemia 9.8
308 spondyloarthropathy 9.8
309 inflammatory spondylopathy 9.8
310 plica syndrome 9.8
311 echinococcosis 9.8
312 alcohol use disorder 9.8
313 kidney cancer 9.8
314 pancreatitis 9.8
315 cholangitis 9.8
316 skeletal dysplasias 9.8
317 carpal tunnel syndrome 9.7
318 nephrolithiasis, calcium oxalate 9.7
319 body mass index quantitative trait locus 11 9.7
320 body mass index quantitative trait locus 9 9.7
321 body mass index quantitative trait locus 8 9.7
322 body mass index quantitative trait locus 4 9.7
323 body mass index quantitative trait locus 10 9.7
324 body mass index quantitative trait locus 7 9.7
325 body mass index quantitative trait locus 12 9.7
326 body mass index quantitative trait locus 14 9.7
327 body mass index quantitative trait locus 18 9.7
328 body mass index quantitative trait locus 19 9.7
329 body mass index quantitative trait locus 20 9.7
330 chondrocalcinosis 9.7
331 nephrotic syndrome 9.7
332 neutropenia 9.7
333 thrombocytopenia 9.7
334 vascular disease 9.7
335 primary hyperoxaluria 9.7
336 plasmacytoma 9.7
337 lung disease 9.7
338 aminoaciduria 9.7
339 juvenile primary osteoporosis 9.7
340 back pain 9.7
341 apert syndrome 9.7
342 klippel-feil syndrome 9.7
343 ehlers-danlos syndrome 9.7
344 fanconi renotubular syndrome 1 9.7
345 fibrodysplasia ossificans progressiva 9.7
346 hypochondroplasia 9.7
347 alcohol dependence 9.7
348 legg-calve-perthes disease 9.7
349 leukemia, chronic lymphocytic 9.7
350 systemic lupus erythematosus 9.7
351 aging 9.7
352 body mass index quantitative trait locus 1 9.7
353 leukemia, acute lymphoblastic 9.7
354 cholangitis, primary sclerosing 9.7
355 mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome 9.7
356 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 9.7
357 mucopolysaccharidosis-plus syndrome 9.7
358 sensorineural hearing loss 9.7
359 heart disease 9.7
360 osteopoikilosis 9.7
361 exocrine pancreatic insufficiency 9.7
362 obstructive jaundice 9.7
363 biliary atresia 9.7
364 sapho syndrome 9.7
365 sclerosing cholangitis 9.7
366 viral hepatitis 9.7
367 enthesopathy 9.7
368 hemoglobinopathy 9.7
369 acute kidney failure 9.7
370 mastocytosis 9.7
371 hemolytic anemia 9.7
372 paraplegia 9.7
373 myeloid leukemia 9.7
374 neurofibromatosis 9.7
375 homocystinuria 9.7
376 48,xyyy 9.7
377 bronchopulmonary dysplasia 9.7
378 growth hormone deficiency 9.7
379 slipped capital femoral epiphysis 9.7
380 hereditary hypophosphatemic rickets 9.7
381 angiomatosis 9.7
382 encephalopathy 9.7
383 myotonia 9.7
384 wilms tumor 5 9.7
385 multiple endocrine neoplasia, type i 9.6
386 colorectal cancer 9.6
387 caffey disease 9.6
388 pseudohypoparathyroidism, type ia 9.6
389 myositis 9.6
390 neurofibromatosis, type i 9.6
391 dowling-degos disease 1 9.6
392 scoliosis, isolated 1 9.6
393 vitiligo-associated multiple autoimmune disease susceptibility 6 9.6
394 enterocolitis 9.6
395 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 9.6
396 hypoascorbemia 9.6
397 myelofibrosis 9.6
398 schwartz-jampel syndrome, type 1 9.6
399 myxedema 9.6
400 osteogenesis imperfecta, type iii 9.6
401 phenylketonuria 9.6
402 prostatic hyperplasia, benign 9.6
403 suppression of tumorigenicity 12 9.6
404 yemenite deaf-blind hypopigmentation syndrome 9.6
405 branchiootic syndrome 1 9.6
406 homocysteinemia 9.6
407 sickle cell anemia 9.6
408 vitiligo-associated multiple autoimmune disease susceptibility 1 9.6
409 scheie syndrome 9.6
410 psoriatic arthritis 9.6
411 hepatitis c virus 9.6
412 gastric cancer 9.6
413 fibroma 9.6
414 colitis 9.6
415 crohn's colitis 9.6
416 idiopathic scoliosis 9.6
417 non-alcoholic fatty liver disease 9.6
418 short bowel syndrome 9.6
419 prostatic hypertrophy 9.6
420 microcytic anemia 9.6
421 otosclerosis 9.6
422 spinal muscular atrophy 9.6
423 acute leukemia 9.6
424 diarrhea 9.6
425 algoneurodystrophy 9.6
426 frozen shoulder 9.6
427 epilepsy 9.6
428 impotence 9.6
429 cerebral palsy 9.6
430 constipation 9.6
431 spondylosis 9.6
432 hemangioma 9.6
433 chondroma 9.6
434 dermatitis 9.6
435 prostatic adenoma 9.6
436 bursitis 9.6
437 adenocarcinoma 9.6
438 multiple endocrine neoplasia 9.6
439 lipid metabolism disorder 9.6
440 lysosomal storage disease 9.6
441 histiocytosis 9.6
442 skin carcinoma 9.6
443 systemic mastocytosis 9.6
444 dentinogenesis imperfecta 9.6
445 hyperglycemia 9.6
446 middle ear disease 9.6
447 plasma cell neoplasm 9.6
448 juvenile rheumatoid arthritis 9.6
449 b-cell lymphoma 9.6
450 peptic ulcer disease 9.6
451 muscular atrophy 9.6
452 gastrointestinal system disease 9.6
453 measles 9.6
454 lupus erythematosus 9.6
455 macroglobulinemia 9.6
456 fatty liver disease 9.6
457 plasma cell leukemia 9.6
458 tenosynovitis 9.6
459 dwarfism 9.6
460 primary bone cancer 9.6
461 spondylarthropathy 9.6
462 bunion 9.6
463 chronic pain 9.6
464 hypoxia 9.6
465 mucopolysaccharidoses 9.6
466 pik3ca-related overgrowth syndrome 9.6
467 overgrowth syndrome 9.6
468 alagille syndrome 1 9.5
469 cleft palate, isolated 9.5
470 crouzon syndrome 9.5
471 boomerang dysplasia 9.5
472 bladder cancer 9.5
473 acroosteolysis 9.5
474 acanthosis nigricans 9.5
475 keratitis, hereditary 9.5
476 marfan syndrome 9.5
477 osteoglophonic dysplasia 9.5
478 papillomatosis, confluent and reticulated 9.5
479 sella turcica, bridged 9.5
480 spondylometaphyseal dysplasia, corner fracture type 9.5
481 sprengel deformity 9.5
482 chromosome 2q35 duplication syndrome 9.5
483 neuropathy, hereditary sensory and autonomic, type iii 9.5
484 ellis-van creveld syndrome 9.5
485 lichtenstein syndrome 9.5
486 multicentric osteolysis, nodulosis, and arthropathy 9.5
487 muenke syndrome 9.5
488 anxiety 9.5
489 spondylocostal dysostosis 3, autosomal recessive 9.5
490 crouzon syndrome with acanthosis nigricans 9.5
491 achondroplasia, severe, with developmental delay and acanthosis nigricans 9.5
492 rhizomelic limb shortening with dysmorphic features 9.5
493 brachydactyly 9.5
494 atelosteogenesis 9.5
495 colorectal adenoma 9.5
496 fibrogenesis imperfecta ossium 9.5
497 stickler syndrome 9.5
498 x-linked chondrodysplasia punctata 2 9.5
499 hereditary multiple exostoses 9.5
500 mood disorder 9.5
501 septic arthritis 9.5
502 degenerative disc disease 9.5
503 exophthalmos 9.5
504 fasciitis 9.5
505 plantar fasciitis 9.5
506 cold-induced sweating syndrome including crisponi syndrome 9.5
507 fgfr craniosynostosis syndromes 9.5
508 flnb disorders 9.5
509 multiple epiphyseal dysplasia, recessive 9.5
510 type ii collagen disorders 9.5
511 fibromatosis multiple non ossifying 9.5
512 horseshoe kidney 9.5
513 simpson-golabi-behmel syndrome 9.5
514 hereditary neuropathies 9.5
515 paraneoplastic syndromes 9.5
516 syncope 9.5
517 ciliopathy 9.5
518 campomelic dysplasia and related disorders 9.5
519 spondyloepiphyseal dysplasia with congenital joint dislocations 9.5
520 osteogenesis imperfecta, type i 9.5
521 wilms tumor 1 9.5
522 arthropathy, progressive pseudorheumatoid, of childhood 9.5
523 osteopetrosis, autosomal recessive 1 9.5
524 spondyloocular syndrome 9.5
525 epiphyseal dysplasia, multiple, 5 9.5
526 aortic aneurysm, familial thoracic 1 9.5
527 complement component 3 deficiency, autosomal recessive 9.5
528 tendinopathy 9.5
529 tendinitis 9.5
530 autonomic neuropathy 9.5
531 epicondylitis 9.5
532 hyperinsulinism 9.5
533 pulmonary tuberculosis 9.5
534 rhabdomyosarcoma 9.5
535 teratocarcinoma 9.5
536 teratoma 9.5
537 aortic aneurysm 9.5
538 blood protein disease 9.5
539 complement component 3 deficiency 9.5
540 vasculitis 9.5
541 myeloid sarcoma 9.5
542 diabetic neuropathy 9.5
543 familial osteochondritis dissecans 9.5
544 rosai-dorfman disease 9.5
545 paresthesia 9.5
546 autosomal recessive malignant osteopetrosis 9.5
547 idiopathic avascular necrosis 9.5
548 lumbar syndrome 9.5
549 esophageal cancer 9.4
550 factor viii deficiency 9.4
551 hypercholesterolemia, familial, 1 9.4
552 gastroesophageal reflux 9.4
553 atherosclerosis susceptibility 9.4
554 arteries, anomalies of 9.4
555 mastocytosis, cutaneous 9.4
556 thyroid carcinoma, familial medullary 9.4
557 metaphyseal chondrodysplasia, schmid type 9.4
558 nevus, epidermal 9.4
559 schimmelpenning-feuerstein-mims syndrome 9.4
560 osteogenesis imperfecta, type iv 9.4
561 gnathodiaphyseal dysplasia 9.4
562 osteomesopyknosis 9.4
563 prolidase deficiency 9.4
564 pheochromocytoma 9.4
565 polyposis, gastric 9.4
566 hutchinson-gilford progeria syndrome 9.4
567 retinal detachment 9.4
568 sarcoidosis 1 9.4
569 scheuermann disease 9.4
570 scleroderma, familial progressive 9.4
571 slipped femoral capital epiphyses 9.4
572 small cell cancer of the lung 9.4
573 neural tube defects 9.4
574 temporal arteritis 9.4
575 down syndrome 9.4
576 alkaptonuria 9.4
577 arachnoid cysts, intracranial 9.4
578 biliary atresia, extrahepatic 9.4
579 tumoral calcinosis, hyperphosphatemic, familial, 1 9.4
580 lung cancer 9.4
581 polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1 9.4
582 persistent hyperplastic primary vitreous, autosomal recessive 9.4
583 lysinuric protein intolerance 9.4
584 hemochromatosis, type 1 9.4
585 hypogonadism, male 9.4
586 chylomicron retention disease 9.4
587 marden-walker syndrome 9.4
588 proteasome-associated autoinflammatory syndrome 1 9.4
589 subacute sclerosing panencephalitis 9.4
590 vitamin d hydroxylation-deficient rickets, type 1a 9.4
591 pseudoxanthoma elasticum 9.4
592 rothmund-thomson syndrome, type 2 9.4
593 sjogren syndrome 9.4
594 thrombocytopenia-absent radius syndrome 9.4
595 vitamin d-dependent rickets, type 2a 9.4
596 dent disease 1 9.4
597 focal dermal hypoplasia 9.4
598 hemophilia a 9.4
599 menkes disease 9.4
600 muscular dystrophy, duchenne type 9.4
601 norrie disease 9.4
602 rett syndrome 9.4
603 diabetes and deafness, maternally inherited 9.4
604 gallbladder disease 1 9.4
605 asthma 9.4
606 dermatitis herpetiformis, familial 9.4
607 stroke, ischemic 9.4
608 stuve-wiedemann syndrome 9.4
609 reflex sympathetic dystrophy 9.4
610 meningioma, radiation-induced 9.4
611 nasopharyngeal carcinoma 9.4
612 creatinine clearance quantitative trait locus 9.4
613 meningioma, familial 9.4
614 coronary heart disease 1 9.4
615 patent ductus arteriosus 1 9.4
616 aural atresia, congenital 9.4
617 parathyroid carcinoma 9.4
618 choanal atresia, posterior 9.4
619 majeed syndrome 9.4
620 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 9.4
621 hyperparathyroidism 3 9.4
622 osteogenesis imperfecta, type vii 9.4
623 osteogenesis imperfecta, type v 9.4
624 ewing sarcoma 9.4
625 inflammatory bowel disease 19 9.4
626 lung cancer susceptibility 3 9.4
627 microvascular complications of diabetes 3 9.4
628 microvascular complications of diabetes 4 9.4
629 microvascular complications of diabetes 6 9.4
630 microvascular complications of diabetes 7 9.4
631 odontoid hypoplasia 9.4
632 osteogenesis imperfecta, type vi 9.4
633 myelodysplastic syndrome 9.4
634 graft-versus-host disease 9.4
635 retinal dystrophy, iris coloboma, and comedogenic acne syndrome 9.4
636 leukemia, acute lymphoblastic 3 9.4
637 nevus comedonicus 9.4
638 helix syndrome 9.4
639 juvenile arthritis 9.4
640 angina pectoris 9.4
641 pulmonary hypertension 9.4
642 congenital hypothyroidism 9.4
643 adult t-cell leukemia 9.4
644 exudative vitreoretinopathy 9.4
645 female breast cancer 9.4
646 paraganglioma 9.4
647 peripheral artery disease 9.4
648 sleep apnea 9.4
649 oral squamous cell carcinoma 9.4
650 adrenal gland pheochromocytoma 9.4
651 lymphoma 9.4
652 pain agnosia 9.4
653 basal ganglia calcification 9.4
654 persistent hyperplastic primary vitreous 9.4
655 inguinal hernia 9.4
656 progressive familial intrahepatic cholestasis 9.4
657 metaphyseal dysplasia 9.4
658 childhood acute lymphocytic leukemia 9.4
659 polycystic kidney disease 9.4
660 non-alcoholic steatohepatitis 9.4
661 dermatomyositis 9.4
662 chronic meningitis 9.4
663 pre-eclampsia 9.4
664 cholesteatoma of middle ear 9.4
665 lipoid nephrosis 9.4
666 sarcoma 9.4
667 vitamin k deficiency bleeding 9.4
668 spinal meningioma 9.4
669 gestational diabetes 9.4
670 iron deficiency anemia 9.4
671 leukocoria 9.4
672 visual epilepsy 9.4
673 cryptococcosis 9.4
674 cartilage disease 9.4
675 male infertility 9.4
676 pancytopenia 9.4
677 hepatitis a 9.4
678 hepatic coma 9.4
679 multiple epiphyseal dysplasia 9.4
680 quadriplegia 9.4
681 dementia 9.4
682 focal segmental glomerulosclerosis 9.4
683 uveitis 9.4
684 acute cystitis 9.4
685 gout 9.4
686 hepatic encephalopathy 9.4
687 tuberous sclerosis 9.4
688 eclampsia 9.4
689 hypermobility syndrome 9.4
690 facial paralysis 9.4
691 childhood type dermatomyositis 9.4
692 ochronosis 9.4
693 gonadal dysgenesis 9.4
694 blount's disease 9.4
695 cystic echinococcosis 9.4
696 urticaria 9.4
697 neuroendocrine tumor 9.4
698 richter's syndrome 9.4
699 ossifying fibroma 9.4
700 calcinosis 9.4
701 hepatitis c 9.4
702 dental caries 9.4
703 craniosynostosis 9.4
704 arteriosclerosis 9.4
705 iron metabolism disease 9.4
706 sensory peripheral neuropathy 9.4
707 hairy cell leukemia 9.4
708 glomerulonephritis 9.4
709 glioblastoma multiforme 9.4
710 lipomatosis 9.4
711 ischemia 9.4
712 fibrosarcoma 9.4
713 bone osteosarcoma 9.4
714 breast adenocarcinoma 9.4
715 breast disease 9.4
716 cellulitis 9.4
717 turner syndrome 9.4
718 skin disease 9.4
719 extramedullary plasmacytoma 9.4
720 solitary osseous plasmacytoma 9.4
721 lung squamous cell carcinoma 9.4
722 thyroid gland medullary carcinoma 9.4
723 nail disease 9.4
724 secondary syphilis 9.4
725 syphilis 9.4
726 spindle cell sarcoma 9.4
727 radiculopathy 9.4
728 erdheim-chester disease 9.4
729 pustulosis of palm and sole 9.4
730 seminoma 9.4
731 secretory meningioma 9.4
732 lymphoplasmacyte-rich meningioma 9.4
733 nutritional deficiency disease 9.4
734 infertility 9.4
735 intestinal disease 9.4
736 peripheral nervous system disease 9.4
737 congestive heart failure 9.4
738 fibromyalgia 9.4
739 acquired immunodeficiency syndrome 9.4
740 inherited metabolic disorder 9.4
741 diffuse idiopathic skeletal hyperostosis 9.4
742 myositis ossificans 9.4
743 cerebrovascular disease 9.4
744 compartment syndrome 9.4
745 t-cell lymphoblastic leukemia/lymphoma 9.4
746 osgood-schlatter's disease 9.4
747 neuroblastoma 9.4
748 tertiary syphilis 9.4
749 cataract 9.4
750 ileus 9.4
751 retinal degeneration 9.4
752 dermatitis herpetiformis 9.4
753 monocytic leukemia 9.4
754 eating disorder 9.4
755 perinatal necrotizing enterocolitis 9.4
756 neuropathy 9.4
757 rosacea 9.4
758 psoriasis 9.4
759 parapsoriasis 9.4
760 diabetes insipidus 9.4
761 smoldering myeloma 9.4
762 neurofibroma 9.4
763 irritable bowel syndrome 9.4
764 muscular dystrophy 9.4
765 hereditary distal renal tubular acidosis 9.4
766 multiple epiphyseal dysplasia, autosomal dominant 9.4
767 plod1-related kyphoscoliotic ehlers-danlos syndrome 9.4
768 trichorhinophalangeal syndrome 9.4
769 al amyloidosis 9.4
770 bone marrow necrosis 9.4
771 bowing of long bones congenital 9.4
772 chromosomal triplication 9.4
773 chronic graft versus host disease 9.4
774 familial tumoral calcinosis 9.4
775 germ cells tumors 9.4
776 lathyrism 9.4
777 leukemia, t-cell, chronic 9.4
778 lymphangiomatosis 9.4
779 medullary sponge kidney 9.4
780 precocious puberty 9.4
781 single ventricular heart 9.4
782 urachal cancer 9.4
783 brain injury 9.4
784 cytomegalovirus infection 9.4
785 dysautonomia 9.4
786 headache 9.4
787 hypotonia 9.4
788 overuse syndrome 9.4
789 seizure disorder 9.4
790 systemic autoimmune disease 9.4
791 rapidly involuting congenital hemangioma 9.4
792 idiopathic nephrotic syndrome 9.4
793 phalangeal microgeodic syndrome 9.4
794 disorders of vitamin d metabolism 9.4
795 familial intrahepatic cholestasis 9.4
796 chondromyxoid fibroma 9.4
797 lysosomal disease 9.4
798 complications after hematopoietic stem cell transplantation 9.4
799 monostotic fibrous dysplasia 9.4
800 primary bone dysplasia with increased bone density 9.4
801 lethal chondrodysplasia 9.4
802 fgfr3-related chondrodysplasia 9.4
803 refractory anemia 9.4
804 vitreoretinopathy 9.4
805 precursor t-cell acute lymphoblastic leukemia 9.4

Graphical network of the top 20 diseases related to Bone Disease:



Diseases related to Bone Disease

Symptoms & Phenotypes for Bone Disease

UMLS symptoms related to Bone Disease:


back pain, bone pain, sciatica, muscle cramp

MGI Mouse Phenotypes related to Bone Disease:

45 (showing 12, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 10.32 ALPL B2M BGLAP CTSK DKK1 EXT1
2 growth/size/body region MP:0005378 10.28 ALPL B2M CTSK DKK1 EXT1 FGF23
3 craniofacial MP:0005382 10.24 ALPL CTSK DKK1 EXT1 FGFR3 PTH
4 hematopoietic system MP:0005397 10.18 ALPL B2M BGLAP CTSK FGF23 FGFR3
5 endocrine/exocrine gland MP:0005379 10.16 ALPL B2M BGLAP CTSK FGF23 PTH
6 immune system MP:0005387 10.15 ALPL B2M BGLAP CTSK FGF23 FGFR3
7 digestive/alimentary MP:0005381 10.13 ALPL B2M CTSK EXT1 FGF23 FGFR3
8 limbs/digits/tail MP:0005371 10.13 ALPL CTSK DKK1 EXT1 FGF23 FGFR3
9 mortality/aging MP:0010768 10.07 ALPL B2M DKK1 EXT1 EXT2 FGF23
10 reproductive system MP:0005389 9.85 ALPL B2M BGLAP CTSK FGF23 FGFR3
11 respiratory system MP:0005388 9.56 ALPL CTSK DKK1 FGF23 FGFR3 RUNX2
12 skeleton MP:0005390 9.5 ALPL BGLAP CTSK DKK1 EXT1 EXT2

Drugs & Therapeutics for Bone Disease

Drugs for Bone Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 379, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Acetaminophen Approved Phase 4 103-90-2 1983
2
Tocopherol Approved, Investigational Phase 4 1406-66-2, 54-28-4 14986
3
Promethazine Approved, Investigational Phase 4 60-87-7 4927
4
Abatacept Approved Phase 4 332348-12-6 10237
5
Diphenhydramine Approved, Investigational Phase 4 58-73-1, 147-24-0 3100
6
alemtuzumab Approved, Investigational Phase 4 216503-57-0
7
Triamcinolone Approved, Vet_approved Phase 4 124-94-7 31307
8
Lactulose Approved Phase 4 4618-18-2 11333
9
Tibolone Approved, Investigational Phase 4 5630-53-5
10
Potassium citrate Approved, Investigational, Vet_approved Phase 4 866-84-2
11
Vildagliptin Approved, Investigational Phase 4 274901-16-5 6918537
12
Gliclazide Approved Phase 4 21187-98-4 3475
13
Norelgestromin Approved, Investigational Phase 4 53016-31-2 13752005
14
Calcium carbonate Approved, Investigational Phase 4 471-34-1
15
Testosterone enanthate Approved Phase 4 315-37-7 9416
16
Testosterone undecanoate Approved, Investigational Phase 4 5949-44-0
17
Testosterone Approved, Experimental, Investigational Phase 4 58-22-0, 481-30-1 10204 6013
18
Methyltestosterone Approved Phase 4 58-18-4 6010
19
Methadone Approved Phase 4 76-99-3 4095
20
Velpatasvir Approved, Investigational Phase 4 1377049-84-7 67683363
21
Naloxone Approved, Vet_approved Phase 4 465-65-6 5284596
22
Buprenorphine Approved, Illicit, Investigational, Vet_approved Phase 4 52485-79-7 40400 644073
23
Sofosbuvir Approved Phase 4 1190307-88-0 45375808
24
Doxorubicin Approved, Investigational Phase 4 23214-92-8 31703
25
Ethinyl Estradiol Approved Phase 4 57-63-6 5991
26
Desogestrel Approved Phase 4 54024-22-5 40973
27
Etonogestrel Approved, Investigational Phase 4 54048-10-1 40976 6917715
28
Teriparatide Approved, Investigational Phase 4 52232-67-4 16133850
29
Tacrolimus Approved, Investigational Phase 4 104987-11-3 445643 439492 6473866
30
Mycophenolic acid Approved Phase 4 24280-93-1 446541
31
Emtricitabine Approved, Investigational Phase 4 143491-57-0 60877
32
Ritonavir Approved, Investigational Phase 4 155213-67-5 392622
33
Prednisone Approved, Vet_approved Phase 4 53-03-2 5865
34
Prednisolone phosphate Approved, Vet_approved Phase 4 302-25-0
35
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 6741
36
Methylprednisolone hemisuccinate Approved Phase 4 2921-57-5
37
Prednisolone Approved, Vet_approved Phase 4 50-24-8 5755
38 Prednisolone acetate Approved, Vet_approved Phase 4 52-21-1
39
Vitamin E Approved, Nutraceutical, Vet_approved Phase 4 59-02-9 14985
40
Ergocalciferol Approved, Nutraceutical Phase 4 50-14-6 5280793
41
Alfacalcidol Approved, Nutraceutical Phase 4 41294-56-8 5282181
42
Calcitriol Approved, Nutraceutical Phase 4 32222-06-3 5280453 134070
43
Vitamin D3 Approved, Nutraceutical Phase 4 67-97-0 5280795 6221
44 Tocotrienol Investigational Phase 4 6829-55-6
45
Tenofovir Experimental, Investigational Phase 4 147127-20-6 464205
46
Prednisolone hemisuccinate Experimental Phase 4 2920-86-7
47 Antirheumatic Agents Phase 4
48 Omega 3 Fatty Acid Phase 4
49 Tocopherols Phase 4
50 Tocotrienols Phase 4
51 Antineoplastic Agents, Immunological Phase 4
52 Liver Extracts Phase 4
53 Mitogens Phase 4
54 Ergocalciferols Phase 4
55 Vitamin D2 Phase 4
56 Triamcinolone diacetate Phase 4
57 triamcinolone acetonide Phase 4
58 Triamcinolone hexacetonide Phase 4
59 Hepcidins Phase 4
60 Antihypertensive Agents Phase 4
61 Androgen Antagonists Phase 4
62 Estrogen Receptor Modulators Phase 4
63 Estrogen Antagonists Phase 4
64 Estrogen Receptor Antagonists Phase 4
65 Dialysis Solutions Phase 4
66 Expectorants Phase 4
67 Hypoglycemic Agents Phase 4
68 Dipeptidyl-Peptidase IV Inhibitors Phase 4
69 Estrogens, Conjugated (USP) Phase 4
70 Hemodialysis Solutions Phase 4
71 Ortho Evra Phase 4
72 Analgesics, Opioid Phase 4
73 Androgens Phase 4
74 Testosterone 17 beta-cypionate Phase 4
75 Genvoya Phase 4
76 Sofosbuvir-velpatasvir drug combination Phase 4
77
Liposomal doxorubicin Phase 4 31703
78 Contraceptives, Oral Phase 4
79 Contraceptives, Oral, Combined Phase 4
80 Antacids Phase 4
81 Anti-Ulcer Agents Phase 4
82 Ibandronic Acid Phase 4
83 Immunoglobulins Phase 4
84 Antibodies Phase 4
85 Calcium, Dietary Phase 4
86 Anti-Bacterial Agents Phase 4
87 Anti-Infective Agents Phase 4
88 Trace Elements Phase 4
89 Micronutrients Phase 4
90 Nutrients Phase 4
91 Vasoconstrictor Agents Phase 4
92 Gastrointestinal Agents Phase 4
93 Immunosuppressive Agents Phase 4
94 Immunologic Factors Phase 4
95 1 alpha-hydroxyergocalciferol Phase 4
96 Protective Agents Phase 4